Condition
Calcific Aortic Stenosis
Total Trials
4
Recruiting
0
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 2 (1)
Trial Status
Completed3
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT04149600Active Not RecruitingPrimary
Identification of Genetic Causes of Calcific Aortic Valve Disease
NCT02132026Phase 2CompletedPrimary
Study Investigating the Effect of Drugs Used to Treat Osteoporosis on the Progression of Calcific Aortic Stenosis.
NCT03343314CompletedPrimary
Effective Management of Calcific Aortic Stenosis in the Elderly
NCT02184442Not ApplicableCompleted
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves - PII B
Showing all 4 trials